REQUEST A DEMO
Total
USD $0.00
Search more companies

Usains Holding Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores | All Other Miscellaneous Schools and Instruction
Full name: Usains Holding Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Providing laboratory and consultancy services, contract research and development, conducting short courses and seminars, management services, sub-letting of office units and equipment and trading

Headquarters
Level 2, Block C, Sains @ Usm, No.10 Persiaran Bukit Jambul
Bayan Lepas; Penang; Postal Code: 11900

Contact Details: Purchase the Usains Holding Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Usains Holding Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Usains Holding Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Usains Holding Sdn. Bhd. report to view the information.
Incorporation Date:
December 17, 1998
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Diagnostics Innovations Sdn. Bhd.
100%
Usains Bio-Engineering Sdn. Bhd.
100%
Usains Biomics Laboratory Testing Services Sdn. Bhd.
100%
Company Performance
Financial values in the chart are available after Usains Holding Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
22.45%
Total operating revenue
22.45%
Operating profit (EBIT)
18.92%
EBITDA
15.18%
Net Profit (Loss) for the Period
17.55%
Total assets
-1.62%
Total equity
9.74%
Operating Profit Margin (ROS)
-0.39%
Net Profit Margin
-0.39%
Return on Equity (ROE)
0.79%
Debt to Equity Ratio
-2.63%
Quick Ratio
0.1%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?